Immunologic changes point to potential for clinical investigation of combination immunotherapy for deadly kidney cancer
Credit: MD Anderson Cancer Center Immunologic changes observed in an early study of patients with metastatic renal cell carcinoma (MRCC) raised the possibility for a...

 
 






